Cefadroxil

Product NDC: 63629-1358
Requested package NDC: 63629-1358-2
11-digit product format: 636291358
Labeler code: 63629
Product ID: 63629-1358_4e03c51e-a386-424c-998e-08b9b2ede0f4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefadroxil
Dosage form: CAPSULE
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA065392
Marketing category: ANDA
Marketing start: 2008-04-23
Marketing end: 0000-00-00
Substance: CEFADROXIL
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	63629-1358	63629-1358-2	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.

Historic NDC status page 1 of 1 · 2 matching rows.

Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63629-1358	63629-1358-2	D	Discontinued by firm		excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63629-1358	63629-1358-2	D	Discontinued by firm		excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065392-001	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	EQ 500MG BASE	CAPSULE / ORAL	AB		2007-05-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065392-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065392-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065392-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065392-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065392-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065392-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065392-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065392-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065392-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065392-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065392-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065392-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065392-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065392-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065392-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065392-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065392-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065392-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065392-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065392-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065392-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065392-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065392-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065392-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065392-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065392-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065392-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065392-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065392-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065392-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065392-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065392-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065392-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065392-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065392-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065392-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065392-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065392-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065392-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065392-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065392-001	AB	1	`cb3db0bc1861…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefadroxil	CEFADROXIL	Proficient Rx LP	57eebea5-28b6-44a3-888b-76950f6038f4	2026-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	REMEDYREPACK INC.	eb365f05-1c8f-4495-b443-abb0580b39fb	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Preferred Pharmaceuticals, Inc.	485bc35b-637a-426b-aaa2-023c664914ae	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Redpharm Drug	1c50c0db-ca03-6217-e063-6294a90a89fa	2025-12-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	NuCare Pharmaceuticals,Inc.	7e931c7e-5ab6-c39c-e053-2a91aa0a59d9	2025-11-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Lupin Pharmaceuticals, Inc.	5fe066ce-2f97-49d7-81bd-a672be1ebecd	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Bryant Ranch Prepack	caee9515-9a10-4020-af47-e9833aa69ef8	2025-06-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	PD-Rx Pharmaceuticals, Inc.	f5bbbf87-f059-4bbd-aea9-27d31462654f	2025-02-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Direct_Rx	f6ddd84a-4a44-7035-e053-6294a90a6606	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Advanced Rx of Tennessee, LLC	205cb17b-6fbf-e147-e063-6294a90a608e	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63629-1358-1	EA - Each	63629-1358	079a1fb2-0cc1-48e1-a907-9f2adc495502	1	2017-06-15
63629-1358-2	EA - Each	63629-1358	103d85b8-3e0c-46c2-b95c-e7cc6809f542	1	2017-06-15
63629-1358-3	EA - Each	63629-1358	07e61b6c-4e6d-4973-9270-99419d7604b7	1	2017-06-15
63629-1358-4	EA - Each	63629-1358	7cdf1604-f1c6-4dfe-af33-e0b2dbc7f112	1	2017-06-15
63629-1358-5	EA - Each	63629-1358	fe3acfe1-bc87-4210-a80c-69f4d7fb01c1	1	2017-06-15
63629-1358-6	EA - Each	63629-1358	ac7f0e24-5aee-4eb4-a658-b06e018a1340	1	2017-06-15
63629-1358-7	EA - Each	63629-1358	5bb88658-8cc2-41ac-9396-a97c778cb089	1	2017-06-15
63629-1358-8	EA - Each	63629-1358	fc41e637-d154-4a78-8d4e-d95628a00300	1	2017-06-15

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
280111G160	CEFADROXIL	66592-87-8	CEFADROXIL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63629-1358-2	63629135802	20 CAPSULE in 1 BOTTLE (63629-1358-2)	20 capsule	2008-04-23	0000-00-00	No	No	Current